SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017248
Filing Date
2016-05-02
Accepted
2016-05-02 07:31:13
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cemp-10q_20160331.htm 10-Q 959578
2 EX-10.36 cemp-ex1036_681.htm EX-10.36 525944
3 EX-31.1 cemp-ex311_8.htm EX-31.1 16918
4 EX-31.2 cemp-ex312_6.htm EX-31.2 16849
5 EX-32.1 cemp-ex321_9.htm EX-32.1 6157
6 EX-32.2 cemp-ex322_7.htm EX-32.2 6079
  Complete submission text file 0001564590-16-017248.txt   4543340

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cemp-20160331.xml EX-101.INS 767468
8 XBRL TAXONOMY EXTENSION SCHEMA cemp-20160331.xsd EX-101.SCH 40758
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20160331_cal.xml EX-101.CAL 30705
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20160331_def.xml EX-101.DEF 103459
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20160331_lab.xml EX-101.LAB 305843
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20160331_pre.xml EX-101.PRE 212214
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 161609735
SIC: 2834 Pharmaceutical Preparations